

浏览全部资源
扫码关注微信
西南交通大学 生命科学与工程学院,成都 610000
Received:19 March 2021,
Published Online:11 May 2021,
Published:20 July 2021
移动端阅览
张留代,熊伟,许青等.基于“心与小肠相表里”探讨松萝抗大鼠动脉粥样硬化及对回肠菌群的影响[J].中国实验方剂学杂志,2021,27(14):36-46.
ZHANG Liu-dai,XIONG Wei,XU Qing,et al.Effect of Usnea diffracta Against Atherosclerosis in Rats and on Microbial Flora of Ileum: An Investigation Based on Interior-exterior Relationship Between Heart and Small Intestine[J].Chinese Journal of Experimental Traditional Medical Formulae,2021,27(14):36-46.
张留代,熊伟,许青等.基于“心与小肠相表里”探讨松萝抗大鼠动脉粥样硬化及对回肠菌群的影响[J].中国实验方剂学杂志,2021,27(14):36-46. DOI: 10.13422/j.cnki.syfjx.20211302.
ZHANG Liu-dai,XIONG Wei,XU Qing,et al.Effect of Usnea diffracta Against Atherosclerosis in Rats and on Microbial Flora of Ileum: An Investigation Based on Interior-exterior Relationship Between Heart and Small Intestine[J].Chinese Journal of Experimental Traditional Medical Formulae,2021,27(14):36-46. DOI: 10.13422/j.cnki.syfjx.20211302.
目的
2
在 “心与小肠相表里”中医理论指导下,探讨松萝治疗动脉粥样硬化(AS)大鼠与回肠肠道菌群的关系。
方法
2
48只SD大鼠随机分为正常组8只和造模组40只,采用高脂饲料联合腹腔注射维生素D
3
建立AS模型。造模组大鼠随机分为5组,模型组、辛伐他汀组(4 mg·kg
-1
)和松萝醇提物低(0.7 g·kg
-1
),中(1.4 g·kg
-1
),高剂量组(2.8 g·kg
-1
),每组8只。干预治疗4周后,收集各组大鼠血液、主动脉、回肠及回肠内容物。酶联免疫吸附法检测大鼠血清脂多糖(LPS),肿瘤坏死因子-
α
(TNF-
α
),白细胞介素-6(IL-6)的含量,苏木素-伊红(HE)染色法检测大鼠胸主动脉病理形态,蛋白免疫印迹法(Western blot)检测大鼠回肠组织紧密连接蛋白闭锁小带蛋白-1(ZO-1),闭合蛋白(Occludin)的蛋白表达,16S rRNA高通量测序技术检测各组大鼠回肠肠道菌群多样性和丰度的变化。
结果
2
与正常组比较,模型组大鼠主动脉斑块沉积明显,血清LPS,TNF-
α
,IL-6的含量均显著升高(
P
<
0.01),回肠组织ZO-1,Occludin的蛋白表达显著降低(
P
<
0.01)。与模型组比较,松萝能明显改善模型大鼠主动脉的斑块沉积,降低血清LPS,TNF-
α
,IL-6的含量(
P
<
0.05,
P
<
0.01),同时提高紧密连接蛋白ZO-1,Occludin的蛋白表达(
P
<
0.05,
P
<
0.01)。与正常组比较,模型组变形菌门Proteobacteria和拟杆菌门Bacteroidetes的丰度发生显著变化,Bacteroidetes/厚壁菌门(Firmicutes)(B/F)明显降低(
P
<
0.05)。Alpha和Beta多样性分析表示模型组肠道菌群物种总数较高,但丰度较低且分布不均(
P
<
0.05,
P
<
0.01),且富集大量致病菌。与模型组比较,松萝醇提物可显著升高B/F值,改善模型大鼠回肠菌群结构的紊乱,降低致病菌、提高益生菌的相对丰度。
结论
2
松萝对AS具有良好的治疗效果,其作用机制可能是与改善肠道菌群结构紊乱,增强肠黏膜屏障,降低血清LPS及炎症因子水平有关。
Objective
2
To explore the correlation between the efficacy of
Usnea diffracta
in treating atherosclerosis (AS) and the altered microbial flora in rat ileum based on the interior-exterior relationship between heart and small intestine in traditional Chinese medicine (TCM).
Method
2
Forty-eight SD rats were randomized into a normal group (
n
=8) and a modeling group (
n
=40). The AS model was established with high-fat diet combined with intraperitoneal injection of vitamin D
3
. The successfully modeled rats were further randomly divided into the model group, positive control (simvastatin, 4 mg·kg
-1
) group, and low- (0.7 g·kg
-1
), medium- (1.4 g·kg
-1
), and high-dose (2.8 g·kg
-1
)
U. diffracta
ethanol extract groups, with eight rats in each group. After four weeks of intervention, the blood, aorta, ileum, and ileum content of rats in each group were collected. The levels of serum lipopolysaccharide (LPS), tumor necrosis factor-
α
(TNF-
α
) and interleukin 6 (IL-6) were measured by enzyme-linked immunosorbent assay (ELISA), and the pathological changes in rat thoracic aorta was detected by hematoxylin-eosin (HE) staining. Western blot was conducted to determine the protein expression levels of tight junction protein zonula occluden (ZO-1) and Occludin in rat ileum, and the high-throughput 16S rRNA sequencing technology was employed to detect changes in microbial diversity and abundance in rat ileum of each group.
Result
2
Compared with the normal group, the model group exhibited obvious aortic plaque deposition, increased LPS, TNF-
α
, and IL-6 levels (
P
<
0.01), but decreased ZO-1 and Occludin protein expression (
P
<
0.01). The comparison with the model group revealed that
U. diffracta
significantly ameliorated the aortic plaque deposition of model rats, lowered serum LPS, TNF-
α
, and IL-6 levels (
P
<
0.05,
P
<
0.01), and up-regulated ZO-1 and Occludin protein expression (
P
<
0.05,
P
<
0.01). The abundance of Proteobacteria and Bacteroidetes in the model group changed significantly in contrast to that in the normal group, and the Bacteroidetes/Firmicutes(B/F) value declined (
P
<
0.05). Alpha and Beta diversity analysis indicated higher total number of intestinal flora species in the model group, but lower richness and uneven distribution (
P
<
0.05,
P
<
0.01), with a large number of pathogenic bacteria enriched. The ethanol extract of
U. diffracta
significantly increased the B/F value, corrected the structural disorder of microbial flora in ileum, reduced pathogenic bacteria, and increased the relative abundance of probiotics.
Conclusion
2
U. diffracta
exerts the therapeutic effect against AS possibly by improving the intestinal microbial communities, strengthening the intestinal mucosal barrier function, and reducing the serum LPS and inflammatory factors.
胡娟 , 汪星辉 , 高杉 , 等 . 肠道菌群在心血管疾病中的作用及其机制研究进展 [J]. 中国药理学通报 , 2019 , 35 ( 11 ): 1496 - 1500 .
袁晓雯 , 姜楠 , 柏冬 , 等 . 桂枝汤调控免疫和肠道菌群抗动脉粥样硬化的作用 [J]. 中国实验方剂学杂志 , 2021 , 27 ( 4 ): 24 - 29 .
NISHIKAWA M , KURANO M , IKEDA H , et al . Lysophosphatidylserine has bilateral effects on macrophages in the pathogenesis of atherosclerosis [J]. J Atheroscler Thromb , 2014 , 22 ( 5 ): 518 - 526 .
李丹 , 李玉洁 , 杨庆 , 等 . 血管内皮功能障碍与动脉粥样硬化研究进展 [J]. 中国实验方剂学杂志 , 2012 , 18 ( 8 ): 272 - 276 .
鞠军亮 , 孟令坡 , 董晓波 , 等 . 通心络胶囊对颅内动脉粥样硬化的临床观察 [J]. 世界中医药 , 2020 , 15 ( 23 ): 3685 - 3689 .
ROSENFELD M E , CAMPBELL L A . Pathogens and atherosclerosis:update on the potential contribution of multiple infectious organisms to the pathogenesis of atherosclerosis [J]. Thrombosis Haemostasis , 2011 , 105 ( 5 ): 858 - 867 .
MATSUZAWA Y , NAKAHASHI H , KONISHI M , et al . Microbiota-derived trimethylamine- N -oxide predicts cardiovascular risk after STEMI [J]. Sci Rep , 2019 , 9 ( 1 ): 11647 .
SUN Y X , WU D B , ZENG W Y , et al . The role of intestinal dysbacteriosis induced arachidonic acid metabolism disorder in inflammaging in atherosclerosis [J]. Front Cell Unfect Mi , 2021 , 11 : 618265 .
LV Z Y , SHAN X , TU Q B , et al . Ginkgolide B treatment regulated intestinal flora to improve high-fat diet induced atherosclerosis in ApoE -/- mice [J]. Biomed Pharmacother , 2021 , 134 ( 1 ): 111100 .
SHEN Y , CHENG Z D , CHEN Y G , et al . Electroacupuncture inhibits atherosclerosis through regulating intestinal flora and host metabolites in rabbit [J]. Evid Based Complementary Altern Med , 2020 , 2020 : 5790275 .
杨东升 . 长松萝活性成分的提取分离与活性测定 [D]. 咸阳 : 西北农林科技大学 , 2007 .
ZHAO X , ZHU J , WANG L , et al . U .diffracta extract mitigates high fat diet and VD 3 -induced atherosclerosis and biochemical changes in the serum liver and aorta of rats [J]. Biomed Pharmacother , 2019 , 120 : 109446 .
CAPORASO J G , LAUBER C L , WALTERS W A , et al . Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample [J]. P Natl Acad Sci USA , 2011 , 108 : 4516 - 4522 .
PRETER V D , RAEMEN H , CLOETENS L , et al . Effect of dietary intervention with different pre- and probiotics on intestinal bacterial enzyme activities [J]. Eur J Clin Nutr , 2008 , 62 ( 2 ): 225 - 231 .
吕晓明 , 宋囡 , 贾连群 , 等 . 基于《内经》“心合小肠”理论探讨肠道菌群与冠心病的关系 [J]. 时珍国医国药 , 2018 , 29 ( 7 ): 1673 - 1675 .
SAYIN S I , WAHLSTROM A , FELIN J , et al . Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid,a naturally occurring FXR antagonist [J]. Cell Metab , 2013 , 17 ( 2 ): 225 - 235 .
HEGADE V S , SPEIGHT R A , ETHERINGTON R E , et al . Novel bile acid therapeutics for the treatment of chronic liver diseases [J]. Ther Adv Gastroenter , 2016 , 9 ( 3 ): 376 - 391 .
TANG W H W , KITAI T , HAZEN S L . Gut microbiota in cardiovascular health and disease [J]. Circ Res , 2017 , 120 ( 7 ): 1183 - 1196 .
KOETH R A , WANG Z , LEVISON B S , et al . Intestinal microbiota metabolism of L -carnitine,a nutrient in red meat,promotes atherosclerosis [J]. Nat Med , 2015 , 19 : 76 - 585 .
FRIEDMAN E S , BITTINGER K , ESIPOVA T V , et al . Microbes vs.chemistry in the origin of the anaerobic gut lumen [J]. P Natl Acad Sci USA , 2018 , 115 ( 16 ): 4170 - 4175 .
LI D , CHEN H , MAO B , et al . Microbial biogeography and core microbiota of the rat digestive tract [J]. Sci Rep , 2017 , 7 ( 1 ): 45840 .
MARTINEZ-GURYN K , LEONE V , CHANG E B . Regional diversity of the gastrointestinal microbiome [J]. Cell Host Microbe , 2019 , 26 ( 3 ): 314 - 324 .
SHIN N , WHON T W , BAE J . Proteobacteria: microbial signature of dysbiosis in gut microbiota [J]. Trends Biotechnol , 2015 , 33 ( 9 ): 496 - 503 .
李丽莎 , 徐小妹 , 卢雪花 , 等 . 泽泻对高脂高糖饮食大鼠肠道菌群多样性的影响 [J]. 中国微生态学杂志 , 2019 , 31 ( 4 ): 396 - 401 .
KIM M S , BYUN J S , YOON Y S , et al . A probiotic combination attenuates experimental colitis through inhibition of innate cytokine production [J]. Benef Microbes , 2017 , 8 ( 2 ): 231 - 241 .
YU O A , MY A , AH A , et al . Severe cellulitis caused by Achromobacter xylosoxidans after allogeneic hematopoietic stem cell transplantation [J]. J Infect Chemother , 2021 , 27 ( 5 ): 770 - 772 .
SHEN F , ZHENG R , SUN X , et al . Gut microbiota dysbiosis in patients with nonalcoholic fatty liver disease [J]. Hepatob Pancreat Dis , 2017 , 16 ( 4 ): 375 - 381 .
KARLSSON F H , FAK F , NOOKAEW I , et al . Symptomatic atherosclerosis is associated with an altered gut metagenome [J]. Nat Commun , 2012 , 3 ( 4 ): 1245 .
陈阳 , 陆杰 , 朱思敏 , 等 . 基于高通量测序技术研究葛根芩连汤及其配伍对急性肠炎大鼠肠道菌群多样性的影响 [J]. 中国中药杂志 , 2020 , 45 ( 6 ): 1406 - 1417 .
CAVALLINI D C , SUZUKI J Y , ABDALLA D S , et al . Influence of a probiotic soy product on fecal microbiota and its association with cardiovascular risk factors in an animal model [J]. Lipids Health Dis , 2011 , 10 : 126 .
OSTOSA MA , RECALDEA D , ZAKINA M M , et al . Implication of natural killer T cells in atherosclerosis development during a LPS-induced chronic inflammation [J]. Febs Letters , 2002 , 519 ( 1/3 ): 23 - 29 .
FURUSE M , FUJITA K , HIIRAGI T , et al . Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to Occludin [J]. J Cell Biol , 1998 , 141 ( 7 ): 1539 - 1550 .
GILANI S , HOWARTH G S , NATTRASS G , et al . Gene expression and morphological changes in the intestinal mucosa associated with increased permeability induced by short-term fasting in chickens [J]. J Anim Physiol An N , 2018 , 102 ( 2 ): e653 - e661 .
LAN T H , HUANG X Q , TAN H M . Vascular fibrosis in atherosclerosis [J]. Cardiovasc Pathol , 2013 , 22 ( 5 ): 401 - 407 .
赵文艳 , 陈曦 . 肠道菌群对动脉粥样硬化性心血管疾病影响的研究进展 [J]. 中国全科医学 , 2019 , 22 ( 27 ): 3292 - 3297 .
ZHANG Y , YANG X , BIAN F , et al . TNF- α promotes early atherosclerosis by increasing transcytosis of LDL across endothelial cells:crosstalk between NF- κ B and PPAR- γ [J]. J Mol Cell Cardiol , 2014 , 72 : 85 - 94 .
ALLEN R A , LEE E M , ROBERTS D H , et al . Polymorphisms in the TNF- α and TNF-receptor genes in patients with coronary artery disease [J]. Eur J Clin Invest , 2015 , 31 ( 10 ): 843 - 851 .
LEINONEN E , HURT-CAMEJO E , WIKLUND O , et al . Insulin resistance and adiposity correlate with acute-phase reaction and soluble cell adhesion molecules in type 2 diabetes [J]. Atherosclerosis , 2003 , 166 ( 2 ): 387 - 394 .
0
Views
21
下载量
4
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution
京公网安备11010802024621